Natixis’s Tenet Healthcare THC Stock Holding History

Natixis’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,250	Closed	-$802K	–	1362
2026 Q1	$802K	Sell	4,250 -26,812	-86%	-$5.65M	﹤0.01%	729
2025 Q4	$6.17M	Buy	31,062 +30,979	+37,324%	+$6.26M	0.02%	419
2025 Q3	$16.9K	Buy	+83	New	+$14.7K	﹤0.01%	974
2025 Q1	–	Sell	-76	Closed	-$9.59K	–	1191
2024 Q4	$9.59K	Sell	76 -17,301	-100%	-$2.57M	﹤0.01%	954
2024 Q3	$2.89M	Buy	+17,377	New	+$2.63M	0.02%	381
2023 Q2	–	Sell	-41,600	Closed	-$2.47M	–	1148
2023 Q1	$2.47M	Sell	41,600 -36,400	-47%	-$2.02M	0.02%	382
2022 Q4	$3.81M	Sell	78,000 -40,000	-34%	-$1.85M	0.02%	427
2022 Q3	$6.09M	Buy	+118,000	New	+$7M	0.03%	366
2022 Q2	–	Sell	-170,100	Closed	-$14.6M	–	1362
2022 Q1	$14.6M	Buy	+170,100	New	+$14M	0.05%	327
2017 Q4	–	Sell	-15,629	Closed	-$257K	–	1161
2017 Q3	$257K	Buy	+15,629	New	+$265K	﹤0.01%	987
2014 Q4	–	Sell	-195,611	Closed	-$11.6M	–	426
2014 Q3	$11.6M	Buy	+195,611	New	+$10.9M	0.18%	101

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Natixis's THC Position: Q2 2026 in Review

Natixis sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 4,250 shares — an estimated $802K sold.

Natixis first reported a position in THC in Q3 2014 and held it in 11 quarters. The position peaked at $14.6M in Q1 2022. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

Natixis reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
Natixis sold 4,250 Tenet Healthcare shares in Q2 2026, an estimated $802K.
Natixis first reported a position in Tenet Healthcare in Q3 2014 and held it in 11 quarters.
Natixis's Tenet Healthcare position peaked at $14.6M in Q1 2022.
681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.